Sign in Subscribe
Cancer

Breakthrough in Metastatic Cancer Treatment: Nanodot-Based Therapy Shows Promise

Strategic Insights

— 1 min read

Researchers from the School of Chemical and Pharmaceutical Engineering have made a significant discovery in the treatment of metastatic cancer. A new study published in the Chemical Engineering Journal has demonstrated the effectiveness of ultrasmall dendrimer nanodots in targeted chemotherapy and enhanced photodynamic/immunotherapy of metastatic cancer. The research has shown that these nanodots can overcome the limitations of conventional photosensitizers (PSs) and improve the efficacy of photodynamic tumor therapy (PDT).

Key Takeaways:

  • The study demonstrates the design engineering of multivalent dendrimer nanodots to overcome the limitations of conventional PSs and improve PDT while enabling synergistic multimodal therapy to prevent cancer metastasis.
  • The nanodots have improved physiological stability and enhanced photodynamic activity, which facilitates localized delivery and controllable release of cisplatin drug in an elevated glutathione tumor microenvironment (TME).
  • The dendrimer nanodots generated higher singlet oxygen (O-1(2)) under laser activation, leading to robust immunogenic cell death (ICD), characterized by calreticulin (CRT) exposure, ATP and HMGB1 release, and dendritic cell (DC) maturation.
  • The study inhibited the growth of primary tumor (similar to 99%) in vivo in an orthotopic 4 T1 breast tumor model and activated systemic antitumor immunity, as evidenced by increased CD8(+) T-cell infiltration and the secretion of pro-inflammatory cytokines, leading to suppress (similar to 98.5%) cancer metastases in vivo.
  • The research concludes that this work demonstrates the design engineering of multivalent dendrimer nanodots to overcome the limitations of conventional PSs to improve PDT while enabling synergistic multimodal therapy to prevent cancer metastasis.
  • Financial supporters for this research include: Natural Science Foundation of Shandong Province, Taishan Scholars Program of Shandong Province.

Statistics:

  • 99% inhibition of primary tumor growth in vivo in an orthotopic 4 T1 breast tumor model.
  • 98.5% suppression of cancer metastases in vivo.
  • CD8(+) T-cell infiltration increased.
  • Pro-inflammatory cytokines secretion increased.
  • Highest singlet oxygen (O-1(2)) generated.

Sources:

  • NewsRx. New Findings from School of Chemical and Pharmaceutical Engineering Update Understanding of Metastatic Cancer (Ultrasmall Polylysine Dendrimer Nanodots for Glutathione-responsive Targeted Chemotherapy and Enhanced Photodynamic/immunotherapy of ...). Cancer Weekly. September 2, 2025; p 699.
  • Chemical Engineering Journal. Ultrasmall Polylysine Dendrimer Nanodots for Glutathione-responsive Targeted Chemotherapy and Enhanced Photodynamic/immunotherapy of Metastatic Cancer. 2025;519.

Read more